Umeclidinium Bromide

CAS 869113-09-7

Overview

Umeclidinium bromide, sold under the brand name Incruse Ellipta, is a long-acting muscarinic antagonist approved for the maintenance treatment of chronic obstructive pulmonary disease

Anant Labs manufacture and furnish high quality Umeclidinium Bromide impurities for global markets. Our Umeclidinium Bromide EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

In Stock

Umeclidinium Bromide

Cat. No. ANTPRD5932Old No. ANT-UMD-00CAS 869113-09-7In Stock

Technical Data

New Cat. No.ANTPRD5932

Old Cat. No.ANT-UMD-00

CAS869113-09-7

Mol. FormulaC₂₉H₃₄BrNO₂

Mol. Weight508.5 g/mol

IUPACdiphenyl-[1-(2-phenylmethoxyethyl)-1-azoniabicyclo[2.2.2]octan-4-yl]methanol bromide

SMILESC1C[N+]2(CCC1(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)CCOCC5=CC=CC=C5.[Br-]

InChIInChI=1S/C29H34NO2.BrH/c31-29(26-12-6-2-7-13-26,27-14-8-3-9-15-27)28-16-19-30(20-17-28,21-18-28)22-23-32-24-25-10-4-1-5-11-25;/h1-15,31H,16-24H2;1H/q+1;/p-1

InChI KeyPEJHHXHHNGORMP-UHFFFAOYSA-M

Synonyms

4-(Hydroxydiphenylmethyl)-1-[2-[(phenylmethyl)oxy]ethyl]-1-azabicyclo[2.2.2]octanium bromideUmeclidinium bromide869113-09-7Incruse ElliptaAnoro Ellipta1-[2-(Benzyloxy)ethyl]-4-(hydroxydiphenylmethyl)-1-quinuclidinium BromideGSK573719AGSK-573719AMFCD27976798bromure d'umeclidinium